These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20881297)

  • 21. PCR-based analysis of herpes simplex virus type 1 latency in the rat trigeminal ganglion established with a ribonucleotide reductase-deficient mutant.
    Ramakrishnan R; Levine M; Fink DJ
    J Virol; 1994 Nov; 68(11):7083-91. PubMed ID: 7933090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between herpes simplex virus type 1 rate of reactivation from latent infection and the number of infected neurons in trigeminal ganglia.
    Maggioncalda J; Mehta A; Su YH; Fraser NW; Block TM
    Virology; 1996 Nov; 225(1):72-81. PubMed ID: 8918535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An M2 Rather than a T
    Lee DH; Ghiasi H
    J Virol; 2018 May; 92(10):. PubMed ID: 29491152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CTCF-dependent chromatin boundary element between the latency-associated transcript and ICP0 promoters in the herpes simplex virus type 1 genome.
    Chen Q; Lin L; Smith S; Huang J; Berger SL; Zhou J
    J Virol; 2007 May; 81(10):5192-201. PubMed ID: 17267480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs.
    Umbach JL; Kramer MF; Jurak I; Karnowski HW; Coen DM; Cullen BR
    Nature; 2008 Aug; 454(7205):780-3. PubMed ID: 18596690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A neuron-specific host microRNA targets herpes simplex virus-1 ICP0 expression and promotes latency.
    Pan D; Flores O; Umbach JL; Pesola JM; Bentley P; Rosato PC; Leib DA; Cullen BR; Coen DM
    Cell Host Microbe; 2014 Apr; 15(4):446-56. PubMed ID: 24721573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone deacetylase inhibitors induce reactivation of herpes simplex virus type 1 in a latency-associated transcript-independent manner in neuronal cells.
    Danaher RJ; Jacob RJ; Steiner MR; Allen WR; Hill JM; Miller CS
    J Neurovirol; 2005 Jul; 11(3):306-17. PubMed ID: 16036811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression.
    Decman V; Kinchington PR; Harvey SA; Hendricks RL
    J Virol; 2005 Aug; 79(16):10339-47. PubMed ID: 16051826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of herpes simplex virus 1-encoded microRNAs in human trigeminal ganglia and their relation to local T-cell infiltrates.
    Held K; Junker A; Dornmair K; Meinl E; Sinicina I; Brandt T; Theil D; Derfuss T
    J Virol; 2011 Oct; 85(19):9680-5. PubMed ID: 21795359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclooxygenase (COX)-inhibiting drug reduces HSV-1 reactivation in the mouse eye model.
    Higaki S; Watanabe K; Itahashi M; Shimomura Y
    Curr Eye Res; 2009 Mar; 34(3):171-6. PubMed ID: 19274523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression analyzed by microarrays in HSV-1 latent mouse trigeminal ganglion following heat stress.
    Hill JM; Lukiw WJ; Gebhardt BM; Higaki S; Loutsch JM; Myles ME; Thompson HW; Kwon BS; Bazan NG; Kaufman HE
    Virus Genes; 2001 Dec; 23(3):273-80. PubMed ID: 11778695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency.
    Perng GC; Dunkel EC; Geary PA; Slanina SM; Ghiasi H; Kaiwar R; Nesburn AB; Wechsler SL
    J Virol; 1994 Dec; 68(12):8045-55. PubMed ID: 7966594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deacetylation of the herpes simplex virus type 1 latency-associated transcript (LAT) enhancer and a decrease in LAT abundance precede an increase in ICP0 transcriptional permissiveness at early times postexplant.
    Amelio AL; Giordani NV; Kubat NJ; O'neil JE; Bloom DC
    J Virol; 2006 Feb; 80(4):2063-8. PubMed ID: 16439563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of herpes simplex virus ICP0 promoter function in sensory neurons during acute infection, establishment of latency, and reactivation in vivo.
    Thompson RL; Shieh MT; Sawtell NM
    J Virol; 2003 Nov; 77(22):12319-30. PubMed ID: 14581568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A herpes simplex virus type 1 mutant disrupted for microRNA H2 with increased neurovirulence and rate of reactivation.
    Jiang X; Brown D; Osorio N; Hsiang C; Li L; Chan L; BenMohamed L; Wechsler SL
    J Neurovirol; 2015 Apr; 21(2):199-209. PubMed ID: 25645379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An HSV-1 chimeric containing HSV-2 latency associated transcript (LAT) sequences has significantly reduced adrenergic reactivation in the rabbit eye model.
    Hill J; Patel A; Bhattacharjee P; Krause P
    Curr Eye Res; 2003; 26(3-4):219-24. PubMed ID: 12815550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression profiling in the HSV-1 latently infected mouse trigeminal ganglia following hyperthermic stress.
    Higaki S; Gebhardt B; Lukiw W; Thompson H; Hill J
    Curr Eye Res; 2003; 26(3-4):231-8. PubMed ID: 12815552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency.
    Cai W; Astor TL; Liptak LM; Cho C; Coen DM; Schaffer PA
    J Virol; 1993 Dec; 67(12):7501-12. PubMed ID: 8230470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence that the herpes simplex virus type 1 ICP0 protein does not initiate reactivation from latency in vivo.
    Thompson RL; Sawtell NM
    J Virol; 2006 Nov; 80(22):10919-30. PubMed ID: 16943285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 2.2-kilobase latency-associated transcript of herpes simplex virus type 2 does not modulate viral replication, reactivation, or establishment of latency in transgenic mice.
    Wang K; Pesnicak L; Guancial E; Krause PR; Straus SE
    J Virol; 2001 Sep; 75(17):8166-72. PubMed ID: 11483762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.